JNJ vs SOLV
By Alex · Tickerpine
Johnson & Johnson vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | SOLV |
|---|---|---|
| Price | $254.66 | $79.53 |
| Market cap | $613.02B | $13.77B |
| P/E ratio | 29.5 | 9.7 |
| ROE | 26.42% | 34.79% |
| Profit margin | 21.83% | 17.33% |
| Revenue growth | 9.90% | -3.00% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs SOLV in plain English
- JNJ is the bigger company — about 44.5× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 9.7 vs 29.5).
- SOLV earns a higher return on equity (35% vs 26%).
- JNJ is growing revenue faster (10% vs -3%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.